Thermo Fisher Scientific Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Marc N. Casper
- Full Time Employees
- 125,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 168 Third Avenue Waltham MA United States of America 02451
- IPO Date
- Mar 17, 1980
- CIK
- 0000097745
- Website
- thermofisher.com
- Similar Companies
- Business
- Thermo Fisher Scientific Inc. (NYSE: TMO) provides analytical instruments, equipment, software, services, consumables, and reagents for research, analysis, discovery, and diagnostics worldwide. The company offers products including mass spectrometry systems, chromatography instruments, genetic analysis tools, bioprocessing equipment, clinical diagnostics assays, laboratory automation solutions, and electron microscopy technologies; its key brands encompass Thermo Scientific, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon. Headquartered in Waltham, Massachusetts, Thermo Fisher was originally founded in 1902 through the merger of Fisher Scientific and Thermo Electron in 2006, and operates in over 70 countries serving pharmaceutical, biotechnology, academic, government, and healthcare customers across life sciences, analytical technologies, specialty diagnostics, and laboratory products segments. Recently, the company expanded its capabilities through the acquisition of Olink Holding AB in 2024 to bolster proteomics offerings, launched the new Orbitrap Astral mass spectrometer in late 2024 for high-throughput proteomics, and formed strategic partnerships including a multi-year collaboration with AstraZeneca to advance biomarker discovery; in 2025, Thermo Fisher announced expansions in gene editing technologies and sustainable manufacturing initiatives amid ongoing supply chain optimizations.
Company News
Pfizer, Thermo Fisher Scientific And More: CNBC's ‘Final Trades'
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
How to Invest in AI Drug Discovery
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy
Is This the Right Time to Add TMO Stock to Your Portfolio?
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High – Time to Buy?
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026
Thermo Fisher Stocks Rise as JPMorgan Adds October Favorite
Thermo Fisher Scientific Inc. $TMO Position Raised by Park National Corp OH
Thermo Fisher Scientific Inc. $TMO Stock Sold by Rockland Trust Co.
Thermo Fisher Scientific Inc. $TMO Stock Acquired by Ferguson Wellman Capital Management Inc.
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study
Thermo Fisher Scientific Inc. $TMO Stock Sold by MassMutual Private Wealth & Trust FSB
Neuralink Stock: How to Invest Before the IPO
The Top HealthTech Questions Landing on Our Desks
Thermo Fisher Scientific Inc (TMO) Stock Up 0.1% but GF Value Says Overvalued -- GF Score: 85/100
Thermo Fisher Scientific (NYSE:TMO) Sets New 1-Year High – Should You Buy?